Valuation: Elutia Inc.

Market Cap 37.91M 34.57M 31.97M 28.85M 54.33M 3.54B 56.48M 386M 153M 1.91B 142M 139M 6.04B P/E 2026 *
-1.29x
P/E 2027 * -1.36x
Enterprise Value 37.91M 34.57M 31.97M 28.85M 54.33M 3.54B 56.48M 386M 153M 1.91B 142M 139M 6.04B EV / Sales 2026 *
5.05x
EV / Sales 2027 * 8.82x
Free-Float
85.22%
Yield 2026 *
-
Yield 2027 * -
1 day-1.63%
1 week-8.15%
Current month+0.94%
1 month+3.66%
3 months-7.14%
6 months-23.18%
Current year+21.99%
1 week 0.79
Extreme 0.7868
0.94
1 month 0.7
Extreme 0.7036
0.96
Current year 0.6
Extreme 0.6019
1.38
1 year 0.5
Extreme 0.5
1.38
3 years 0.5
Extreme 0.5
5.24
5 years 0.5
Extreme 0.5
9.01
10 years 0.5
Extreme 0.5
18.2
Manager TitleAgeSince
Chief Operating Officer 52 -
Chief Executive Officer 54 21/06/2022
Director of Finance/CFO 58 28/09/2020
Director TitleAgeSince
Chairman 65 01/11/2015
Director/Board Member 54 01/11/2015
Director/Board Member 70 01/09/2020
Date Insider Type Main position Quantity % Market Cap. Importance
9/10/26 A Exercice

Founder

63,884 0.1445%
9/10/26 A Exercice

Founder

29,269 0.0662%
9/10/26 A Exercice

Chief Financial Officer

29,486 0.0667%
Change 5-day change 1-year change 3-year change Capi.($)
-1.04%-8.15%+21.36%-47.84% 37.82M
-2.21%-3.65%+34.45%+131.74% 1,261B
-1.94%-2.44%+36.78%+82.48% 671B
-2.32%-2.94%+22.42%+107.00% 518B
-0.69%+0.40%+40.46%+69.78% 387B
-3.81%-6.26%+43.07%+34.36% 353B
-1.35%-2.23%+24.30%+56.34% 300B
-1.13%-1.71%+0.40%+33.00% 283B
-3.12%-5.02%+29.25%+67.56% 248B
-0.60%-0.29%+33.06%+122.67% 211B
Average -1.93%-0.48%+28.55%+65.71% 423B
Weighted average by Cap. -2.06%-0.55%+31.25%+90.95%

Financials

2026 *2027 *
Net sales 7.5M 6.84M 6.32M 5.71M 10.75M 701M 11.17M 76.38M 30.19M 378M 28.14M 27.55M 1.19B 4.3M 3.92M 3.63M 3.27M 6.16M 402M 6.41M 43.79M 17.31M 217M 16.13M 15.79M 685M
Net income -27.3M -24.9M -23.02M -20.77M -39.13M -2.55B -40.67M -278M -110M -1.38B -102M -100M -4.35B -23.6M -21.52M -19.9M -17.96M -33.82M -2.21B -35.16M -240M -95.01M -1.19B -88.54M -86.68M -3.76B
Net Debt - -
Projected Income Statement - Annual - Elutia Inc.
Logo Elutia Inc.
Elutia Inc. is a commercial-stage company developing proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. Its cardiovascular biomatrix portfolio spans pericardial closure, intracardiac tissue repair, and vascular reconstruction. In Cardiovascular, it sells its specialized porcine small intestine submucosa for use as an intracardiac and vascular patch, as well as for pericardial reconstruction. Its cardiovascular products are specifically designed to provide immediate structural support while promoting tissue regeneration, cellular infiltration, and natural integration over time. It is focused on developing NXT-41x, an antibiotic-eluting biomatrix designed to address post-operative infection. The NXT-41x product is designed to provide soft-tissue reinforcement while locally delivering antibiotics locally to inhibit bacterial colonization at the surgical site.
Employees
26
Date Price Change Volume
18/11/26 $0.8450 -1.04% 11,689
17/11/26 $0.8539 +3.77% 49,962
16/11/26 $0.8229 +0.35% 53,867
13/11/26 $0.8200 -6.69% 50,439
12/11/26 $0.8788 -4.48% 83,188
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.8539USD
Average target price
5.000USD
Spread / Average Target
+485.55%
  1. Stock Market
  2. Stocks
  3. ELUT Stock